Drugs / gp140 DP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02315703 | Dec 2014 → Aug 2017 | — | Janssen Vaccines & Prevention B.V. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp140 DP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02315703 ↗ |
| Modality | Vaccine | “The gp140 DP vaccine containing 50 mcg of total protein” NCT02315703 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT02315703 ↗ |